These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21683832)

  • 1. Elevated natriuretic peptide levels and cognitive function in community-dwelling older adults.
    Daniels LB; Laughlin GA; Kritz-Silverstein D; Clopton P; Chen WC; Maisel AS; Barrett-Connor E
    Am J Med; 2011 Jul; 124(7):670.e1-8. PubMed ID: 21683832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
    Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
    J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study.
    Daniels LB; Barrett-Connor E; Clopton P; Laughlin GA; Ix JH; Maisel AS
    J Am Coll Cardiol; 2012 Mar; 59(12):1101-9. PubMed ID: 22421304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk.
    Wijsman LW; Sabayan B; van Vliet P; Trompet S; de Ruijter W; Poortvliet RK; van Peet PG; Gussekloo J; Jukema JW; Stott DJ; Sattar N; Ford I; Westendorp RG; de Craen AJ; Mooijaart SP
    Ann Neurol; 2014 Aug; 76(2):213-22. PubMed ID: 24942833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study.
    Daniels LB; Clopton P; Laughlin GA; Maisel AS; Barrett-Connor E
    Circulation; 2011 May; 123(19):2101-10. PubMed ID: 21536998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Terminal Pro-B-Type Natriuretic Peptide Is Related to Retinal Microvascular Damage: The Rotterdam Study.
    Mutlu U; Ikram MA; Hofman A; de Jong PT; Klaver CC; Ikram MK
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1698-702. PubMed ID: 27339461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study.
    Singh HS; Bibbins-Domingo K; Ali S; Wu AH; Schiller NB; Whooley MA
    Clin Cardiol; 2009 Aug; 32(8):447-53. PubMed ID: 19685518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
    Price AH; Welsh P; Weir CJ; Feinkohl I; Robertson CM; Morling JR; McLachlan S; Strachan MW; Sattar N; Price JF
    Diabetologia; 2014 Dec; 57(12):2505-12. PubMed ID: 25231020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: a 10-year follow-up study in the general population.
    Mirza SS; de Bruijn RF; Koudstaal PJ; van den Meiracker AH; Franco OH; Hofman A; Tiemeier H; Ikram MA
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):356-62. PubMed ID: 25918047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
    Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
    Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study.
    Patton KK; Sotoodehnia N; DeFilippi C; Siscovick DS; Gottdiener JS; Kronmal RA
    Heart Rhythm; 2011 Feb; 8(2):228-33. PubMed ID: 21044699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
    Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
    Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.
    Doi Y; Ninomiya T; Hata J; Hirakawa Y; Mukai N; Ikeda F; Fukuhara M; Iwase M; Kiyohara Y
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2997-3003. PubMed ID: 21921261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly.
    Eggers KM; Lindahl B; Venge P; Lind L
    Int J Cardiol; 2018 Apr; 257():300-305. PubMed ID: 29506712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
    DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
    Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study.
    Rutten JH; Mattace-Raso FU; Steyerberg EW; Lindemans J; Hofman A; Wieberdink RG; Breteler MM; Witteman JC; van den Meiracker AH
    Hypertension; 2010 Mar; 55(3):785-91. PubMed ID: 20083731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
    Eggers KM; Venge P; Lind L
    Am J Cardiol; 2013 Jan; 111(1):131-6. PubMed ID: 23040598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.